The Chemours Company $CC Shares Acquired by Geode Capital Management LLC

Geode Capital Management LLC lifted its holdings in shares of The Chemours Company (NYSE:CC) by 41.4% in the second quarter, HoldingsChannel.com reports. The firm owned 3,484,416 shares of the specialty chemicals company’s stock after acquiring an additional 1,020,933 shares during the quarter. Geode Capital Management LLC’s holdings in Chemours were worth $39,901,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Millennium Management LLC increased its position in shares of Chemours by 60.4% during the first quarter. Millennium Management LLC now owns 4,022,782 shares of the specialty chemicals company’s stock valued at $54,428,000 after acquiring an additional 1,515,520 shares during the last quarter. Bryce Point Capital LLC acquired a new position in shares of Chemours in the 2nd quarter worth approximately $955,000. Bank of New York Mellon Corp boosted its position in shares of Chemours by 8.8% during the 2nd quarter. Bank of New York Mellon Corp now owns 1,054,620 shares of the specialty chemicals company’s stock worth $12,075,000 after purchasing an additional 85,529 shares during the period. Wealth Enhancement Advisory Services LLC increased its holdings in Chemours by 18.6% in the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 12,994 shares of the specialty chemicals company’s stock valued at $149,000 after purchasing an additional 2,039 shares during the last quarter. Finally, Versor Investments LP acquired a new stake in Chemours in the 2nd quarter valued at approximately $412,000. 76.26% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on the company. UBS Group lowered their price target on Chemours from $21.00 to $18.00 and set a “buy” rating for the company in a research report on Tuesday, November 11th. Truist Financial lowered their target price on Chemours from $21.00 to $18.00 and set a “buy” rating for the company in a report on Monday, November 10th. Zacks Research downgraded Chemours from a “hold” rating to a “strong sell” rating in a research report on Friday, October 17th. Mizuho reduced their price target on shares of Chemours from $19.00 to $18.00 and set an “outperform” rating on the stock in a research report on Thursday, October 16th. Finally, Royal Bank Of Canada lowered their price objective on shares of Chemours from $19.00 to $17.00 and set an “outperform” rating for the company in a research note on Monday, November 10th. Five equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $17.50.

Chemours Stock Up 1.3%

Shares of Chemours stock opened at $12.49 on Thursday. The company has a quick ratio of 0.88, a current ratio of 1.71 and a debt-to-equity ratio of 13.66. The Chemours Company has a 52-week low of $9.13 and a 52-week high of $22.38. The company has a market capitalization of $1.87 billion, a P/E ratio of -5.62 and a beta of 1.64. The company has a 50 day moving average of $13.73 and a 200 day moving average of $13.21.

Chemours (NYSE:CC) last announced its quarterly earnings data on Thursday, November 6th. The specialty chemicals company reported $0.20 earnings per share for the quarter, missing analysts’ consensus estimates of $0.24 by ($0.04). The firm had revenue of $1.50 billion during the quarter, compared to analyst estimates of $1.50 billion. Chemours had a negative net margin of 5.70% and a positive return on equity of 35.27%. Chemours’s revenue for the quarter was down .9% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.40 earnings per share. Chemours has set its Q4 2025 guidance at EPS. FY 2025 guidance at EPS. As a group, research analysts forecast that The Chemours Company will post 2.03 EPS for the current fiscal year.

Chemours Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, December 15th. Shareholders of record on Friday, November 14th will be issued a dividend of $0.0875 per share. This represents a $0.35 dividend on an annualized basis and a yield of 2.8%. The ex-dividend date of this dividend is Friday, November 14th. Chemours’s payout ratio is -15.77%.

Chemours Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.